Vitamin D and Type 2 diabetes mellitus

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 261-267

  Xuan, Yan ^a   Zhao, Hong Yan ^a   Liu, Jian Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Insulin resistance; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

ADIPONECTIN; CALCIUM; COLECALCIFEROL; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROINSULIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOCYTE; BODY MASS; CARDIOVASCULAR MORTALITY; DISEASE ASSOCIATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; VITAMIN D;

ANIMALS; CALCIUM; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN-SECRETING CELLS; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84881552197     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12024     Document Type: Review

References (81)

1. Hu FB, Manson JE, Stampfer MJ etal. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001; 345: 790-797.
2. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997; 40: 344-347.
3. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79: 820-825.
4. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 2813-2818.
5. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28: 1228-1230.
6. Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005; 62: 738-741.
7. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care. 2006; 29: 2244-2246.
8. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose intolerance is associated with altered calcium homeostasis: A possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism. 1997; 46: 1171-1177.
9. Snijder M, van Dam R, Visser M, Deeg D, Seidell J, Lips P. To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247-1257. Diabetologia. 2006; 49: 217-218.
10. Kayaniyil S, Vieth R, Retnakaran R etal. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010; 33: 1379-1381.
11. Karnchanasorn R, Ou HY, Chiu KC. Plasma 25-hydroxyvitamin D levels are favorably associated with beta-cell function. Pancreas. 2012; 41: 863-868.
12. Hartaigh B, Thomas GN, Silbernagel G etal. Association of 25-hydroxyvitamin D with type 2 diabetes among patients undergoing coronary angiography: Cross-sectional findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Clin Endocrinol (Oxf). 2012. doi: 10.1111/cen.12024.
13. Gradinaru D, Borsa C, Ionescu C, Margina D, Prada GI, Jansen E. Vitamin D status and oxidative stress markers in elderly with impaired fasting glucose and Type 2 diabetes mellitus. Aging Clin Exp Res. 2012; 24: 595-602.
14. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005; 28: 2926-2932.
15. Pittas AG, Dawson-Hughes B, Li T etal. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006; 29: 650-656.
16. Knekt P, Laaksonen M, Mattila C etal. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008; 19: 666-671.
17. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr. 2011; 65: 1005-1015.
18. Liu E, Meigs JB, Pittas AG etal. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr. 2010; 91: 1627-1633.
19. Husemoen LL, Thuesen BH, Fenger M etal. Serum 25(OH)D and type 2 diabetes association in a general population: A prospective study. Diabetes Care. 2012; 35: 1695-1700.
20. Gagnon C, Lu ZX, Magliano DJ etal. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: Results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab. 2012; 97: 1953-1961.
21. Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012; 55: 1668-1678.
22. Forouhi NG, Ye Z, Rickard AP etal. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012; 55: 2173-2182.
23. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies. Proc Nutr Soc. 2013; 72: 89-97.
24. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010; 33: 2238-2243.
25. Oh J, Weng S, Felton SK etal. 1, 25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009; 120: 687-698.
26. Riek AE, Oh J, Sprague JE etal. Vitamin d suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J Biol Chem. 2012; 287: 38482-38494.
27. Nunlee-Bland G, Gambhir K, Abrams C, Abdul M, Vahedi M, Odonkor W. Vitamin D deficiency and insulin resistance in obese African-American adolescents. J Pediatr Endocrinol Metab. 2011; 24: 29-33.
28. Khor GL, Chee WS, Shariff ZM etal. High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia. BMC Public Health. 2011; 11: 95.
29. Reis JP, von Muhlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009; 124: e371-379.
30. Olson ML, Maalouf NM, Oden JD, White PC, Hutchison MR. Vitamin D deficiency in obese children and its relationship to glucose homeostasis. J Clin Endocrinol Metab. 2012; 97: 279-285.
31. Barr SI. Increased dairy product or calcium intake: Is body weight or composition affected in humans? J Nutr. 2003; 133: 245S-248.
32. Shapses SA, Heshka S, Heymsfield SB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab. 2004; 89: 632-637.
33. Gunther CW, Legowski PA, Lyle RM etal. Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr. 2005; 81: 751-756.
34. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008; 7: 4.
35. Ou HY, Karnchanasorn R, Lee LZ, Chiu KC. Interaction of BMI with vitamin D and insulin sensitivity. Eur J Clin Invest. 2011; 41: 1195-1201.
36. Kabadi SM, Lee BK, Liu L. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: Results from the NHANES 2001-2006. Diabetes Care. 2012; 35: 2048-2054.
37. Husemoen LLN, Skaaby T, Thuesen BH, Jørgensen T, Fenger RV, Linneberg A. Serum 25(OH)D and incident type 2 diabetes: A cohort study. Eur J Clin Nutr. 2012; 66: 1309-1314.
38. Miñambres I, Sánchez-Hernández J, Sánchez-Quesada JL, Rodríguez J, de Leiva A, Pérez A. The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol. 2012; 2012: 691803.
39. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr. 2012; 95: 1055-1059.
40. Poomthavorn P, Saowan S, Mahachoklertwattana P, Chailurkit L, Khlairit P. Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics. Int J Obes (Lond). 2012; 36: 491-495.
41. Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984; 8: 407-411.
42. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008; 25: 320-325.
43. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009; 48: 349-354.
44. Zittermann A, Frisch S, Berthold HK etal. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009; 89: 1321-1327.
45. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - A randomized, placebo-controlled trial. Br J Nutr. 2010; 103: 549-555.
46. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007; 30: 980-986.
47. de Boer IH, Tinker LF, Connelly S etal. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008; 31: 701-707.
48. Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994; 59: 1083-1087.
49. Ljunghall S, Lind L, Lithell H etal. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance - A prospective randomized double-blind study. Acta Med Scand. 1987; 222: 361-367.
50. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest. 1997; 27: 629-633.
51. Bowen J, Noakes M, Clifton PM. Effect of calcium and dairy foods in high protein, energy-restricted diets on weight loss and metabolic parameters in overweight adults. Int J Obes (Lond). 2005; 29: 957-965.
52. Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005; 13: 1344-1353.
53. Sánchez M, de la Sierra A, Coca A, Poch E, Giner V, Urbano-Márquez A. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension. 1997; 29: 531-536.
54. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004; 12: 582-590.
55. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013; 36: 260-266.
56. Harris SS, Pittas AG, Palermo NJ. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab. 2012; 14: 789-794.
57. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92: 2017-2029.
58. Bland R, Markovic D, Hills CE etal. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004; 89: 121-125.
59. Maestro B, Davila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003; 84: 223-230.
60. Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1, 25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999; 160: 87-95.
61. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1, 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000; 47: 383-391.
62. Chiu KC, Chuang LM, Lee NP etal. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism. 2000; 49: 1501-1505.
63. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007; 30: 1549-1555.
64. Rubin MR, Silverberg SJ. Glucose intolerance and primary hyperparathyroidism: An unresolved relationship. Endocrine. 2012; 42: 231-233.
65. Zhao L, Liu J-M, He X-Y etal. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: Data from 2000-2010 in a single clinical center. J Clin Endocrinol Metab. 2013; 98: 721-728.
66. Christakos S, Gabrielides C, Rhoten WB. Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology. Endocr Rev. 1989; 10: 3-26.
67. Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr. 2010; 92: 1344-1349.
68. Xue B, Greenberg AG, Kraemer FB, Zemel MB. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001; 15: 2527-2529.
69. Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Parathyroid response to vitamin D insufficiency: Relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol (Oxf). 2008; 69: 29-35.
70. Wolden-Kirk H, Overbergh L, Gysemans C etal. Unraveling the effects of 1, 25(OH)(2)D(3) on global gene expression in pancreatic islets. J Steroid Biochem Mol Biol. 2013; 136: 68-79.
71. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53: 693-700.
72. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286: 327-334.
73. Duncan BB, Schmidt MI, Pankow JS etal. Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes. 2003; 52: 1799-1805.
74. Timms PM, Mannan N, Hitman GA etal. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM. 2002; 95: 787-796.
75. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006; 29: 722-724.
76. Shab-Bidar S, Neyestani TR, Djazayery A etal. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012; 28: 424-430.
77. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796-1808.
78. Marcotorchino J, Gouranton E, Romier B etal. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res. 2012; 56: 1771-1782.
79. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract. 2007; 77: 47-57.
80. Krishnan AV, Moreno J, Nonn L, Swami S, Peehl DM, Feldman D. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: Role of anti-inflammatory activity. J Bone Miner Res. 2007; 22(Suppl. 2): V74-80.
81. Manna P, Jain SK. Vitamin D upregulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem. 2012; 287: 42324-42332.